MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.25
-1.12 (-6.45%)
Jan 16, 2026, 4:00 PM EST - Market closed
MediWound Market Cap
MediWound has a market cap or net worth of $208.35 million as of January 16, 2026. Its market cap has increased by 7.81% in one year.
Market Cap
208.35M
Enterprise Value
157.53M
1-Year Change
7.81%
Ranking
Category
Stock Price
$16.25
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $208.35M, a decrease of -20.69%. That is a compound annual growth rate of -1.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 222.71M | -5.90% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |